Ross Moat
Corporate Officer/Principal at KINIKSA PHARMACEUTICALS, LTD.
Net worth: 309 407 $ as of 2024-05-30
Network origin in Ross Moat first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 26 | |
17
| Extinct | Biotechnology | 17 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ross Moat via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
| Rochester Christian University | College/University | Undergraduate Degree Undergraduate Degree | |
| INTERMUNE INC | Biotechnology | Corporate Officer/Principal Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
| SEAGEN INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
Baker Bros. Advisors LP
 Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Investment Managers | Founder Portfolio Manager-Equities | |
| GENOMIC HEALTH, INC. | Medical Specialties | Director/Board Member Chief Executive Officer Director of Finance/CFO | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ORGANOVO HOLDINGS, INC. | Biotechnology | Director of Finance/CFO | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree | |
The Colorado College
 The Colorado College Other Consumer ServicesConsumer Services Colorado College provide a broad liberal arts education to students. The college was founded in May 6, 1874 and it is headquartered in Colorado Springs, CO | College/University | Undergraduate Degree | |
| San Jose State University | College/University | Masters Business Admin Undergraduate Degree | |
| University of California San Diego | College/University | Doctorate Degree | |
| University of Illinois | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree | |
| St. Lawrence University | College/University | Undergraduate Degree | |
| PANACOS PHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO | |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Director/Board Member Founder | |
| Venrock Healthcare Capital Partners LP | Investment Managers | Corporate Officer/Principal | |
| The University of North Carolina at Charlotte | College/University | Masters Business Admin Undergraduate Degree | |
Milo Biotechnology LLC
 Milo Biotechnology LLC BiotechnologyHealth Technology Milo Biotechnology LLC develops novel therapies based on follistatin, a protein that increases muscle mass and strength. The firm is targeting rare neuromuscular diseases, initiating a phase I/II clinical trial in Becker muscular dystrophy and inclusion body myositis. The company was founded by Al Hawkins and Brian K. Kaspar in January 2012 and is headquartered in Cleveland, OH. | Biotechnology | Founder | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Boston College Law School | College/University | Graduate Degree Graduate Degree | |
| Wallace E Carroll School of Management | College/University | Masters Business Admin Masters Business Admin | |
| 4D MOLECULAR THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal President | |
| Questrom School of Business | College/University | Masters Business Admin | |
KSQ Therapeutics, Inc.
 KSQ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
Kiniksa Pharmaceuticals Corp.
 Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Part of Kiniksa Pharmaceuticals Ltd., Kiniksa Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic medicines for patients suffering from debilitating diseases. The company is based in Lexington, MA. The CEO of the company is Sanj K. Patel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Director of Finance/CFO | |
Levo Therapeutics, Inc.
 Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Biotechnology | Chairman Director/Board Member Corporate Officer/Principal | |
| KODIAK SCIENCES INC. | Biotechnology | Director/Board Member Director/Board Member | |
| TALIS BIOMEDICAL CORPORATION | Medical Specialties | Chairman Director/Board Member | |
| TAYSHA GENE THERAPIES, INC. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member President Founder | |
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a clinical stage biotechnology company based in Lake Forest, IL. Jaguar Gene Therapy LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company has a proven team of experts who have experience in bringing novel gene therapy treatments to patients and their families. Jaguar is rapidly advancing an initial pipeline of three programs, including targeting severe neurodevelopmental disorders, type 1 galactosemia, and type 1 diabetes. The company partner with Advanced Medicine Partners for manufacturing their therapeutics. Key investors include Deerfield Management Company, Arch Venture Partners, and Eli Lilly and Company. The company was founded by Daniel Gallo, and Joseph Nolan has been the CEO since 2020. | Medical/Nursing Services | Director of Finance/CFO Chairman Chief Tech/Sci/R&D Officer | |
Genomic Life, Inc.
 Genomic Life, Inc. Medical/Nursing ServicesHealth Services Wamberg Genomic Advisors, Inc. engages in the provision of genomic-based programs and services. It offers a comprehensive cancer support program that provide an individual and their family with the dedicated resources, technology, and genetic testing needed to navigate cancer while improving chances of survival. The company was founded in 2017 and is headquartered in San Diego, CA. | Medical/Nursing Services | Director/Board Member Director of Finance/CFO | |
| DIANTHUS THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO General Counsel |
Statistics
International
| United States | 50 |
| Canada | 2 |
Sectoral
| Health Technology | 32 |
| Consumer Services | 14 |
| Finance | 3 |
| Health Services | 3 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 184 |
| Corporate Officer/Principal | 93 |
| Independent Dir/Board Member | 86 |
| Undergraduate Degree | 35 |
| Chairman | 32 |
Most connected contacts
| Insiders | |
|---|---|
| Felix Baker | 28 |
| Paul Manning | 26 |
| Daniel Welch | 24 |
| Kim Popovits | 19 |
| Sean Nolan | 18 |
| Thomas Malley | 17 |
| Richard Levy | 16 |
| Frank Verwiel | 16 |
| Philip Donenberg | 15 |
| Sukumar Nagendran | 15 |
| Carsten Boess | 15 |
| Joao Siffert | 14 |
| Bong Koh | 14 |
| R. Session | 13 |
| Barry Quart | 13 |
- Stock Market
- Insiders
- Ross Moat
- Company connections
